Diagnostic News and Research

RSS

Toshiba America Medical Systems releases new cardiac CT software for Aquilion systems

Responding to the cardiac CT market’s need for superior image quality with lower radiation doses, Toshiba America Medical Systems, Inc., has unveiled new cardiac software enhancements available now for the Aquilion® ONE and Aquilion Premium CT systems. The new cardiac CT software package is designed to reduce radiation exposure while maintaining outstanding image quality.

1 Mar 2010

Axolotl to demonstrate Elysium Open Access platform during HIMSS 2010

Axolotl Corp., the most experienced health information exchange (HIE) solutions and services company, today announced that it will be demonstrating its standards-based service-oriented architecture (SOA) platform — Elysium Open Access, with live third party applications – in operation today. Elysium Open Access is a core part of Axolotl’s Elysium® Exchange HIE suite.

1 Mar 2010

Determining personal risk for genetic disorders essential

Genetic diseases affect an estimated 12 million Americans, yet according to a survey of 1,000 people conducted by the Genetic Disease Foundation (GDF), while two-thirds of those surveyed were willing to and saw the benefits of undergoing genetic testing, close to 80 percent had never talked to their physician about genetic screening – an inconsistency that can have serious implications on a person's overall health and the health of their immediate family members.

1 Mar 2010

New method using SGR to calculate rate of tumour growth developed

When treating cancer, it is an advantage to know the rate of growth of the cancer tumour. The standard method currently used to determine tumour growth, however, is erroneous. This is the conclusion of scientists at the University of Gothenburg, Sweden, who have developed a new model.

1 Mar 2010

Diagosis of head and neck lesions: Ultrasound-guided FNA better than standard palpation technique

Office-based, surgeon-performed, ultrasound-guided, fine needle aspiration (FNA) of head and neck lesions yields a statistically significant higher diagnostic rate compared to the standard palpation technique, indicates new research in the March 2010 issue of Otolaryngology - Head and Neck Surgery.

1 Mar 2010

Cotton thread as core material in 'lab-on-chip' devices to detect kidney failure and diabetes

A discovery by Monash University scientists could see humble cotton thread emerge as a core material in low-cost 'lab-on-chip' devices capable of detecting diseases such as kidney failure and diabetes.

27 Feb 2010

Researchers develop noninvasive infrared scanning system to diagnose melanomas

Johns Hopkins researchers have developed a noninvasive infrared scanning system to help doctors determine whether pigmented skin growths are benign moles or melanoma, a lethal form of cancer.

27 Feb 2010

Phadia AB plans to provide access for specialists to peanut allergen components

Today, at the 2010 Annual Meeting of The American Academy of Allergy, Asthma & Immunology (AAAAI) Phadia, the world leader in in vitro allergy diagnostics, announced plans to provide access for specialists to peanut allergen components. These plans support Phadia’s goal to expand collaboration with allergy and immunology specialists in order to advance the understanding of the clinical utility of allergen component test results.

27 Feb 2010

Federal officials focus on radiation practices at Florida clinic; Medical scan makers announce new efforts to prevent mistakes

Medicare regulations require that when patients receive some types of highly specialized cancer treatments, their radiation oncologist must be on site. But The New York Times reports that federal officials are investigating a Florida cancer clinic that billed Medicare for such treatments while the doctors were absent, sometimes on overseas trips.

27 Feb 2010

Magellan Health Services reports net revenue of $2.64 billion for year ended December 31, 2009

Magellan Health Services, Inc. today reported net revenue of $2.64 billion, net income of $106.7 million, or $3.01 per diluted common share, and segment profit of $227.2 million for the year ended December 31, 2009.

26 Feb 2010

Advances in surgical technology enable surgeons to perform many operations as outpatient procedures

Nearly 58 percent of the surgeries performed in hospitals were done as outpatient procedures, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.

26 Feb 2010

UCLA School of Nursing selects CytoCore's PadKit Collection Kit for comparative cytology study of cervical cancer

CytoCore Inc., the developer of cost-effective products used in the practice of cytology for the detection and diagnosis of cancer and cancer related diseases, announced today that PadKit® Collection Kit, a transport kit using an intralabial device for the collection of gynecological samples, has been selected by the UCLA School of Nursing as the sample collection system for a comparative cytology study of cervical cancer.

26 Feb 2010

Genoptix to participate in Aetna's national provider network to offer laboratory and diagnostic services

Genoptix, Inc. today announced that it will participate in Aetna's (AET) national provider network to offer specialized laboratory and comprehensive diagnostic services designed to optimize the care of patients suffering from hematomalignancies, or cancers of the blood and bone marrow, including leukemia and lymphoma.

26 Feb 2010

Nanotechnology to tackle side effects and drug resistance in treatment of cancer

Huixin He, associate professor, nanoscale chemistry at Rutgers University, Newark, and Tamara Minko, professor at the Rutgers Ernest Mario School of Pharmacy, have developed a nanotechnology approach that potentially could eliminate the problems of side effects and drug resistance in the treatment of cancer. Under traditional chemotherapy, cancer cells, like bacteria, can develop resistance to drug therapy, leading to a relapse of the disease.

26 Feb 2010

imaGenes GmbH passes certification process to qualify as Roche NimbleGen CSP for DNA Methylation Analysis

Roche NimbleGen is pleased to announce that imaGenes GmbH, located in Berlin, Germany, has passed the certification process to qualify as a Roche NimbleGen Certified Service Provider for DNA Methylation Analysis. imaGenes is a solution provider for functional genomics and proteomics with a comprehensive portfolio of high-quality services for molecular life sciences.

26 Feb 2010

EVA trial: MRI is more accurate for early diagnosis of breast cancer than digital mammography

Do we need a revision of current recommendations for breast cancer screening? According to a recent prospective multicenter cohort study published in the "Journal of Clinical Oncology", this appears advisable at least for young women carrying an increased risk of breast cancer. The results of the EVA trial confirm once more that magnetic resonance imaging (MRI) is substantially more accurate for early diagnosis of breast cancer than digital mammography or breast ultrasound: MRI is three times more sensitive for breast cancer than digital mammography.

26 Feb 2010

MITA announces new radiation dose safeguards for expansively addressing patient safety in medical imaging

As part of its ongoing commitment to ensuring safe, appropriate and effective medical imaging and radiation therapy, the Medical Imaging & Technology Alliance (MITA) announced today a new industry-wide commitment to more expansively address patient safety in medical imaging by including new radiation dose safeguards.

26 Feb 2010

Pall Corporation announces next generation, 96-well AcroPrep Advance filter plates

Pall Corporation, a global leader in filtration, separation and purification, has introduced its next generation 96-well filter plate that delivers consistency and reproducibility in applications, such as neonatal screening and multiplexing. The Pall AcroPrep Advance filter plate employs new design features that provide uniform filtration rates, lowers hold-up volumes and ensures consistent sample/bead recovery from the wells.

From Pall Corporation 26 Feb 2010

NeoGenomics' fourth-quarter revenue up 32%

NeoGenomics, Inc., a leading provider of cancer-focused genetic testing services today reported its results for the fourth quarter 2009 and fiscal year ended December 31, 2009.

25 Feb 2010

Stereotaxis' revenue for recent fourth-quarter increases 16%

Stereotaxis, Inc. today reported its financial results for the quarter and the year ended December 31, 2009. Revenue for the recent fourth quarter grew 16% to $14.1 million compared with $12.1 million in the same quarter a year ago.

25 Feb 2010

Diagnostic News and Research

Toshiba America Medical Systems releases new cardiac CT software for Aquilion systems

Axolotl to demonstrate Elysium Open Access platform during HIMSS 2010

Determining personal risk for genetic disorders essential

New method using SGR to calculate rate of tumour growth developed

Diagosis of head and neck lesions: Ultrasound-guided FNA better than standard palpation technique

Cotton thread as core material in 'lab-on-chip' devices to detect kidney failure and diabetes

Researchers develop noninvasive infrared scanning system to diagnose melanomas

Phadia AB plans to provide access for specialists to peanut allergen components

Federal officials focus on radiation practices at Florida clinic; Medical scan makers announce new efforts to prevent mistakes

Magellan Health Services reports net revenue of $2.64 billion for year ended December 31, 2009

Advances in surgical technology enable surgeons to perform many operations as outpatient procedures

UCLA School of Nursing selects CytoCore's PadKit Collection Kit for comparative cytology study of cervical cancer

Genoptix to participate in Aetna's national provider network to offer laboratory and diagnostic services

Nanotechnology to tackle side effects and drug resistance in treatment of cancer

imaGenes GmbH passes certification process to qualify as Roche NimbleGen CSP for DNA Methylation Analysis

EVA trial: MRI is more accurate for early diagnosis of breast cancer than digital mammography

MITA announces new radiation dose safeguards for expansively addressing patient safety in medical imaging

Pall Corporation announces next generation, 96-well AcroPrep Advance filter plates

NeoGenomics' fourth-quarter revenue up 32%

Stereotaxis' revenue for recent fourth-quarter increases 16%

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News